The Democratic National Committee is launching a new website today to show the impact of President Donald Trump’s tariffs and ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

The sector-specific tariffs are putting pressure on businesses and foreign nations as they try to navigate Trump’s constantly ...

Johnson & Johnson (JNJ) has reportedly revised its forecast of the impact of U.S. President Donald Trump’s tariffs to $200 ...

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...

The EU as a whole has an annual trade surplus with the United States of $235.6 billion, according to the Bureau of Economic ...